Drug developer Adamas moves closer to $62 million IPO

Adamas Pharmaceuticals Inc. will offer nearly 3.5 million shares at $16 to $18 in an IPO, raising more than $62 million, the company said in a regulatory filing Wednesday...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.